From October 28, 2021 to December 31, 2021, the company has repurchased 15,335,700 shares, representing 0.98% for ¥49,979.94 million. With this, the company has completed the repurchase of 15,335,700 shares, representing 0.98% for ¥49,979.94 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,122 JPY | -0.15% | +0.02% | +1.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.68% | 41.85B | |
+25.46% | 659B | |
+26.69% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.51% | 215B | |
+7.53% | 210B | |
-6.30% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.